Sugi Predict

Sugi Predict / Compounds / SCHEMBL2874397

SCHEMBL2874397

SCHEMBL2874397

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC(CO)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.39
▸ CNR1 P21554 4/20 0.39
▸ CNR2 P34972 3/20 0.39
▸ MAPT P10636 2/20 0.35
▸ FAAH O00519 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ OXER1 Q8TDS5 3/20 0.34
▸ CYP19A1 P11511 2/20 0.34
▸ RXRA P19793 2/20 0.34
▸ PPARG P37231 2/20 0.34
▸ FFAR1 O14842 1/20 0.34
▸ TSHR P16473 2/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ PTGS1 P23219 2/20 0.33
▸ ADORA3 P0DMS8 2/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ PPARA Q07869 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3690382 1.00 ALDH1A1 (0.39) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3687188 0.94 ALDH1A1 (0.42) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL4558174 0.82 ALDH1A1 (0.41) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL2872687 0.82 ALDH1A1 (0.41) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL13169162 0.81 ALDH1A1 (0.44) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3684216 0.81 ALDH1A1 (0.44) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3685580 0.79 CNR1 (0.50) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3686867 0.79 CNR1 (0.50) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3694351 0.78 ALDH1A1 (0.45) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3688799 0.77 ALDH1A1 (0.51) ALDH1A1CNR1CNR2MAPTFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2010508262-A — — 2010-03-18 — — JP claimed
EP-2102139-A2 OMEGA-3 LIPID COMPOUNDS Pronova Biopharma Norge AS (NO) 2009-09-23 — — EP claimed
WO-2008142482-A2 OMEGA-3 LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (US) 2008-11-27 — — WO claimed
US-20100240616-A1 NOVEL LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (NO) 2010-09-23 — — US disclosed
US-20100240616-A1 NOVEL LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (NO) 2010-09-23 — — US disclosed
US-20100240616-A1 NOVEL LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (NO) 2010-09-23 — — US disclosed
EP-2129646-A2 OMEGA-3 LIPID COMPOUNDS Pronova Biopharma Norge AS (NO) 2009-12-09 — — EP disclosed
EP-2102139-A2 OMEGA-3 LIPID COMPOUNDS Pronova Biopharma Norge AS (NO) 2009-09-23 — — EP disclosed
WO-2008142482-A2 OMEGA-3 LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (US) 2008-11-27 — — WO disclosed
WO-2008132552-A2 OMEGA-3 LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (US) 2008-11-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240616-A1 NOVEL LIPID COMPOUNDS ELOVL3, FFAR3, STARD3 ALDH1A1 2317/4885CNR1 258/4885CNR2 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.